Thus, we suggest that the contrary role of GSK3β shown in our iPSC-based results compared with that indicated in previous non-patient-derived ALS cell or animal results demonstrates the major value of using patient cell-derived MNs as a model. The gene discussed is GSK3B; the disease is amyotrophic lateral sclerosis.